Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.220 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Ansuman Dash und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Biofilm formation is a major virulence factor of Candida species and plays a crucial role in persistent infections and reduced antifungal susceptibility. The increasing prevalence of Candida non-albicans species with variable biofilm-forming capacity and antifungal resistance poses significant therapeutic challenges, particularly in hospitalized patients.
Aim
The aim of the study is to contribute clinically relevant data to the evolving understanding of biofilmassociated candidiasis and to support evidence-based therapeutic strategies in hospital settings. Materials & Methods: A prospective laboratory-based study was conducted in a tertiary care teaching hospital in eastern India from November 2013 to September 2015. A total of 400 clinical samples were processed, yielding 150 culture-positive Candida isolates. Species identification was performed using conventional phenotypic methods, chromogenic media, biochemical tests, and automated identification systems. Biofilm production was assessed using Congo red agar and tube methods. Antifungal susceptibility testing was carried out by the Kirby–Bauer disc diffusion method using polyenes and azole antifungal agents. Data were analyzed descriptively and expressed as frequencies and percentages.
Results
Candida non-albicans species constituted 66% of isolates. Biofilm production was detected in 73 (48.7%) isolates by Congo red agar and in 132 (88%) isolates by the tube method. Strong biofilm formation (3+) was observed in 27.3% of isolates, with Candida non-albicans species demonstrating slightly higher overall biofilm positivity than Candida albicans. Antifungal susceptibility testing showed highest sensitivity to nystatin (89%) and amphotericin B (88%), whereas overall susceptibility to azole antifungals was comparatively low (34%). Voriconazole and clotrimazole were the most effective agents among azoles.
Conclusion
The study highlights a high prevalence of biofilm-forming Candida species, particularly among non-albicans isolates, associated with reduced azole susceptibility. Routine assessment of biofilm production and antifungal susceptibility is essential to guide effective therapy and strengthen antifungal stewardship in hospital settings.
Zitieren
APA
Dash, A., Pattnaik, D., Poddar, N., & Mishra, M. (2026). Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.220
Vancouver
Dash A, Pattnaik D, Poddar N, Mishra M. Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.220
BibTeX
@article{Dash2026,
author = {Dash, Ansuman and Pattnaik, Dipti and Poddar, Nirmala and Mishra, Madhushree},
title = {Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.220}
}
EUVIMED